- $26.43bn
- $25.60bn
- $1.68bn
2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 422 | 590 | 874 | 1,284 | 1,683 |
Cost of Revenue | |||||
Gross Profit | 296 | 413 | 614 | 935 | 1,259 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 570 | 800 | 1,163 | 1,631 | 1,917 |
Operating Profit | -148 | -209 | -289 | -347 | -234 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -176 | -263 | -303 | -333 | -164 |
Provision for Income Taxes | |||||
Net Income After Taxes | -176 | -267 | -307 | -345 | -177 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -176 | -267 | -307 | -345 | -177 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -176 | -267 | -307 | -345 | -177 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -3.14 | -4.53 | -4.75 | -5.03 | -2.48 |